Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Echo Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Echo Therapeutics Inc market cap is $2,400.00.
What is the 52-week high for Echo Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Echo Therapeutics Inc 52 week high is $0.28 as of October 03, 2025.
What is the 52-week low for Echo Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Echo Therapeutics Inc 52 week low is $0.00 as of October 03, 2025.
What is Echo Therapeutics Inc stock price today?
Echo Therapeutics Inc stock price today is $0.0002.
What was Echo Therapeutics Inc stock price yesterday?
Echo Therapeutics Inc stock price yesterday was $0.0001.
What is the 50-day moving average of Echo Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Echo Therapeutics Inc 50-day moving average is $0.0005.